「the」の検索結果
159件：86～90件目を表示
-
お知らせ | 千寿製薬株式会社
August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-7...
https://www.senju.co.jp/english/news/ -
; hereinafter “Senju”) hereby announces that it has entered into a LicensingAgreement for Corneal Esthesiometer Brill in Japan with Brill International (Headquarters: Barcelona, Spain; CEO: Jordi Mart...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Japan as an option of RET-700, effect...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906_0.pdf -
. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in Japan, effective immediately (medical device approval numbe...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for dry-eye analysis in Japan as an option of RET-700, effect...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf